Literature DB >> 8709283

Interaction of the adenovirus L1 52/55-kilodalton protein with the IVa2 gene product during infection.

K E Gustin1, P Lutz, M J Imperiale.   

Abstract

The adenovirus L1 52/55-kDa protein is expressed both in the early and late stages of infection, raising the possibility that it has multiple roles in the viral life cycle. To obtain possible insights into these roles, the yeast two-hybrid system was used to examine the interactions of the 52/55-kDa protein with viral and cellular factors. cDNA expression libraries from human 293 cells at both early and late stages of adenovirus type 5 infection were constructed and screened, with the 52/55-kDa protein being used as bait. Characterization of positive clones revealed that the adenovirus IVa2 gene product interacted specifically with the 52/55-kDa protein. In addition, the IVa2 protein was shown to interact with a bacterial glutathione S-transferase-52/55-kDa fusion protein in vitro, further supporting the finding with the yeast two-hybrid system. Finally, coimmunoprecipitation studies confirmed that the 52/55-kDa protein and IVa2 polypeptide interact specifically during the course of adenovirus infection. A potential role for the IVa2-52/55-kDa protein interaction in the regulation of transcription from the major late promoter and in viral assembly is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709283      PMCID: PMC190681          DOI: 10.1128/JVI.70.9.6463-6467.1996

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.

Authors:  P Lutz; C Kedinger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Inhibition of adenovirus replication by 1-beta-D-arabinofuranosylcytosine.

Authors:  L A Feldman; F Rapp
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

4.  Correlation of two-hybrid affinity data with in vitro measurements.

Authors:  J Estojak; R Brent; E A Golemis
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

5.  The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter.

Authors:  C Tribouley; P Lutz; A Staub; C Kedinger
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  RNA structures near poly(A) of adenovirus-2 late messenger RNAs.

Authors:  N Fraser; E Ziff
Journal:  J Mol Biol       Date:  1978-09-05       Impact factor: 5.469

7.  BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control.

Authors:  K F Harris; J B Christensen; M J Imperiale
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA.

Authors:  P Aleström; G Akusjärvi; M Perricaudet; M B Mathews; D F Klessig; U Pettersson
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

9.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

10.  Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.

Authors:  J Gyuris; E Golemis; H Chertkov; R Brent
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  31 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Minimal cis-acting elements required for adenovirus genome packaging.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro.

Authors:  Pilar Perez-Romero; Ryan E Tyler; Johanna R Abend; Monica Dus; Michael J Imperiale
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome.

Authors:  Philomena Ostapchuk; Mary E Anderson; Sharanya Chandrasekhar; Patrick Hearing
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence.

Authors:  Pilar Perez-Romero; Kurt E Gustin; Michael J Imperiale
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein.

Authors:  Ryan E Tyler; Sean G Ewing; Michael J Imperiale
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription.

Authors:  Humayra Ali; Gary LeRoy; Gemma Bridge; S J Flint
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

8.  Role for the L1-52/55K protein in the serotype specificity of adenovirus DNA packaging.

Authors:  Beverly P Wohl; Patrick Hearing
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  Presence of the adenovirus IVa2 protein at a single vertex of the mature virion.

Authors:  Joan B Christensen; Serena A Byrd; Angela K Walker; John R Strahler; Philip C Andrews; Michael J Imperiale
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

10.  Adenovirus IVa2 protein binds ATP.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.